Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID‐19 pandemic: The Princess Margaret experience and proposal

202060 citationsJournal Articlehybrid Open Access

Authors

Shao Hui Huang · Princess Margaret Cancer Centre

Brian O’Sullivan · Princess Margaret Cancer Centre

Jie Su · University of Toronto

Jolie Ringash · Princess Margaret Cancer Centre

Scott V. Bratman · Princess Margaret Cancer Centre

John Kim · Princess Margaret Cancer Centre

Ali Hosni

Abstract

It is proposed that RT-hypo be considered in place of CCRT for HPV+ T1-T3N0-N2c (TNM-7) HNSCCs, HPV- T1-T2N0 HNSCCs, and select stage III HNSCCs during the COVID-19 outbreak.

Topics & Keywords

Head and Neck Cancer Studies COVID-19 and healthcare impacts Lung Cancer Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cancer

Volume 126, Issue 15, pp. 3426-3437

DOI: 10.1002/cncr.32968

Field-Weighted Citation Impact: 8.50